Compositions and methods for modifying genomes
AssigneeBenson Hill Biosystems, Inc.
InventorsMatthew Begemann, Benjamin Neil Gray
Life of this patent
Estimating the term…
Loading patent…
AssigneeBenson Hill Biosystems, Inc.
InventorsMatthew Begemann, Benjamin Neil Gray
Estimating the term…
Compositions and methods for modifying genomic DNA sequences are provided. The methods produce double-stranded breaks (DSBs) at pre-determined target sites in a genomic DNA sequence, resulting in mutation, insertion, and/or deletion of DNA sequences at the target site(s) in a genome. Compositions comprise DNA constructs comprising nucleotide sequences that encode a Cpf1 or Csm1 protein operably linked to a promoter that is operable in the cells of interest. The DNA constructs can be used to direct the modification of genomic DNA at pre-determined genomic loci. Methods to use these DNA constructs to modify genomic DNA sequences are described herein. Additionally, compositions and methods for modulating the expression of genes are provided. Compositions comprise DNA constructs comprising a promoter that is operable in the cells of interest operably linked to nucleotide sequences that encode a mutated Cpf1 or Csm1 protein with an abolished ability to produce DSBs, optionally linked to a domain that regulates transcriptional activity. The methods can be used to up- or down-regulate the expression of genes at predetermined genomic loci.
A method of modifying a nucleotide sequence at a target site in the genome of a eukaryotic cell comprising:
A method of modifying a nucleotide sequence at a target site in the genome of a prokaryotic cell comprising:
A nucleic acid molecule comprising a polynucleotide sequence encoding a Csm1 polypeptide, wherein said polynucleotide sequence has at least 95% identity with a sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.